Home » Stocks » ELTX

Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: $12.00 - $14.00
Current IPO price range
Market Cap 180.42M
Revenue (ttm) n/a
Net Income (ttm) -18.90M
Shares Out 13.88M
EPS (ttm) -1.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Elicio Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About ELTX

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. For therapies designed to engage the immune system to treat disease, it is critical to target activation at the unique location where adaptive immune responses are generated. Our proprietary Amphiphile, or AMP, platform delivers immunotherapeutics directly to the “brain center” of the immune system - the lymph nodes. We believe this site-specific delivery of disease-specific antigens, a... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Robert Connelly
Employees
22
Stock Exchange
NASDAQ
Ticker Symbol
ELTX
Full Company Profile

Financial Performance

Financial Statements